Market open · Delayed intraday data · 10:05 AM ET
Last update: Jul 21, 2026, 10:04 AM ET
West Pharmaceutical Services, Inc.
$352.32 1.65% at Jul 20 close
Market Open

Why West Pharmaceutical Services, Inc. (WST) stock moved

Updated Jul 20, 2026

West Pharmaceutical Services, Inc. (WST) shares fell 1.7% to $352.32 at the July 20, 2026 close, a modest decline from the prior close of $358.24. That close is the latest confirmed price for WST; a live quote was not available. BestStocks flagged the session as a major change for WST. The move is tied to a new SEC filing. Below, we break down what changed for WST, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

SEC Filing

West Pharmaceutical Services, Inc. (WST) filed an 8-K on July 14, 2026. The filing content was not disclosed in available sources. Review the full 8-K filing on the SEC website to determine what material event was reported.

This summary describes the catalyst and move as first detected on Jul 14, 2026, 4:43 PM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
FilingsWeak confidence
Rel. volume
Calculating
Vs peers
No comparable peers
Market cap
Earnings in
2d
2026-07-23
Price chart
Jul 21
Not enough price data.
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for West Pharmaceutical Services, Inc. investors

For West Pharmaceutical Services, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Negative session, down 1.7%; New SEC filing — review for material disclosures. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 2 days out, the next report is the most likely near-term test of the move.

WST price reaction

WST last traded at $352.32, down $5.92 (-1.65%) from the previous close of $358.24.

The bull and bear case for WST stock

Weighing the constructive signals against the risks, here is how the bull and bear case for West Pharmaceutical Services, Inc. (WST) lines up on the latest data.

The bullish case

  • Positive price momentum.

The bearish case

  • Negative session, down 1.7%.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst expectations
No analyst data available
SEC filings watch
8-K2026-07-14
Material event — review for impact
high
8-K2026-06-01
Material event — review for impact
high
8-K2026-05-11
Material event — review for impact
high
8-K2026-05-05
Material event — review for impact
high
Peer context
WST-1.7%

Previous notable changes for WST

Activity2026-07-02via PR Newswire
WST rose 1.02% to $366.67 following the company's announcement on July 1, 2026, that it completed the sale and transfer of manufacturing and supply rights for its SmartDose® 3.5mL On-Body Delivery System. The divestiture removes a product line from West's portfolio.
Activity2026-07-01via zacks.com
WST rose 0.79% to $361.85 intraday on below-average volume (0.60x expected), with no concrete catalyst event identified beyond a generic value-comparison article versus Merit Medical published July 1.
Filings2026-06-01
West Pharmaceutical Services (WST) filed an 8-K on June 1, 2026, with no accompanying price movement recorded (0%).
Material / Earnings2026-04-23
West Pharmaceutical Services (WST) reported EPS of $2.13 for Q1 FY2026, beating the consensus estimate of $1.68 by 26.8%. The stock moved 26.79% following the earnings report.
Upcoming catalysts & outlook
Next earnings
2026-07-23
in 2 days
Thesis shift
Neutral / Mixed
bearish signal
Risk level
Low
from change events

Frequently asked questions about WST

Why did West Pharmaceutical Services, Inc. (WST) stock move?

WST fell 1.7% to $352.32. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.

How much did WST stock fall?

WST lost 1.65% ($5.92) versus the prior close of $358.24, last trading at $352.32.

When is West Pharmaceutical Services, Inc.'s next earnings date?

WST's next earnings report is scheduled for 2026-07-23 — about 2 days away.

How BestStocks tracks WST

This page is generated automatically by BestStocks' change-detection system after a new SEC filing was detected and verified against independent data sources. It draws on 5 tracked change events for WST, cross-checked against the data sources listed below. A live intraday quote was not available, so price and volume figures are the confirmed end-of-day close from July 20, 2026 — not the current price — and the percentage move is that session's. They refresh once live quotes resume. For companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesEarnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.